SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: snowpile5 who wrote (2267)4/4/1997 2:04:00 PM
From: Harvey Allen   of 4342
 
For a while we thought Mr. Rhodes was going to sell his stock:

********************************************************************
Name of Beneficial Owner Amount and Nature Percent of Class
of Beneficial
Ownership

Keith A. Rhodes
Ithaca, NY 14850 714,000 (1) 6.1%

(1) Includes 2,500 shares issuable upon exercise of currently
exercisable common stock purchase warrants.
*********************************************************************

but instead we have Mr. Babish selling his:

*********************************************************************
John G. Babish, Ph.D.
Ithaca, NY 14850 723,100 (2) 6%

(2) Includes 375,300 shares issuable upon exercise of currently
exercisable common stock purchase warrants.

*********************************************************************

Burn rate is still 1 year as far as I know.

Wonder if the hand of Travelers was in the attracting of Mr.
Alberts to PRLN?

Harvey

P.S. April 6, 1997 is the deadline for the East/West purchase.
We should be hearing something.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News